Colin Farlow & Matt Kovac: “How to Manage Your Company Board”

How do you manage your board as CEO of a biotech startup? Join us Tuesday, August 13 to learn from Colin Farlow, co-founder of Serotiny, in a conversation moderated by Matt Kovac of Wilson Sonsini.

Register for the Livestream

About the Speakers

Colin Farlow

Colin Farlow cofounded Serotiny, a Bay Area biotech focused on designing therapeutic multi-domain proteins for gene and cell therapies. Colin earned his JD from University of Wisconsin Law School and started Serotiny to apply scalable technologies to gene and cell therapy discovery. Serotiny strategically partnered with leading biotech and Pharma, including Johnson & Johnson, which led to the company’s acquisition of Serotiny.

Matt Kovac

Matt Kovac is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. Prior to attending law school, Matt worked in the legal departments of several Bay Area tech companies.